-
Having automatic external defibrillators, or AEDs, installed in the workplace is of clear benefit, but there are a number of key strategies that should be followed to ensure program success, says Thomas W. Zoch, MD, FACP, FACEP, of Thedacare at Work in Appleton, WI.
-
ACOEM supports immigration reform; OSHA delays enforcement of TB standard to July; Survey finds vacancies, turnover; AHIMA releases EHR standards
-
-
-
-
-
When should placebos be used in clinical research? Can subjects with a medical condition be asked to consent to withdraw from their current medications and take an experimental medication with the 50/50 chance that what they actually receive will be no medication at all?
-
The Genetic Modification Clinical Research Information System (GeMCRIS), a web-based data system designed to assist researchers and others involved in human gene therapy studies, manages information about science and safety of clinical trials in this field. Three years in development, the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) jointly launched GeMCRIS at the end of March.
-
For clinical trials administrators and investigators who desire best practices in human subjects protection, there can be no better place to start than with research staff education. Education and training of research staff and investigators traditionally was provided in the form of a mentoring program in which a junior person learned from a senior person, says Ruth Fischbach, PhD, MPE, director of the Center for Bioethics at Columbia University in New York City.
-
During a presentation at the 2004 Annual Scientific Congress of the Royal Australasian College of Surgeons, held May 2-7 in Melbourne, Australia, Jonathan Lewis, MD, PhD, a former cancer researcher at Memorial Sloan-Kettering Cancer Center in New York City and the New Haven, CT-based Yale University School of Medicine, called for changes in oncology clinical trial design.
